Lv3
324 积分 2023-06-19 加入
Incidence and Prognostic Impact of Crh in Acute Myeloid Leukemia
21天前
已完结
Population Pharmacokinetic and Exposure-Response Analysis to Support a Dosing Regimen of CPX-351 (NS-87) in Japanese Adult and Pediatric Patients with Untreated High-Risk Acute Myeloid Leukemia
1个月前
已关闭
The signaling pathways activated by ROR1 in cancer
2个月前
已完结
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
2个月前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
2个月前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
2个月前
已完结
Targeting the undruggable: menin inhibitors ante portas
3个月前
已完结
Menin Inhibitors in Acute Myeloid Leukemia-What Does the Future Hold?
3个月前
已完结
Menin inhibitors in the treatment of acute myeloid leukemia
3个月前
已完结
Menin inhibitors in the treatment of acute myeloid leukemia
3个月前
已关闭
皖公网安备34019202002308
